United States Services, news and resources from United States Tweet Jump to NewsNews in other languages News Treatment outcomes Treatment with DAAs reduces the risk of mortality in the first 18 months after the completion of treatment Michael Carter / 10 August 2017 For the first time, a large study has demonstrated that treatment with direct-acting antivirals (DAAs) significantly reduces mortality rates among people with hepatitis C virus (HCV) monoinfection. The study – ... Pan-genotypic regimens European and US regulators approve AbbVie's new combo for all hepatitis C genotypes Liz Highleyman / 08 August 2017 The European Commission and the US Food and Drug Administration (FDA) last week approved AbbVie's new combination pill for people with hepatitis C virus (HCV) genotypes 1 to 6, to ... Pharmaceutical industry AbbVie Mavyret Price Threatens Gilead Hepatitis Dominance Bloomberg / 07 August 2017 Treatment for people living with HIV and HCV Gilead Sciences Announces FDA Approves Expanded Labeling for Epclusa Gilead press release / 02 August 2017 Finance, funding & health economics Reining in Drug Prices: Easier Said than Done MedPage Today / 02 August 2017 More news News in other languages AIDS Impact: Factores de riesgo y de tipo predictivo en personas coinfectadas por VIH y VHC gTt / 02 October 2013 IAS 2013: FibroScan predice de forma precisa el riesgo de descompensación hepática y muerte en pacientes coinfectados gTt / 31 July 2013 Arritmias relacionadas con el uso de metadona en EE UU gTt / 29 July 2013 Hoy, 28 de julio, la Organización Mundial de la Salud conmemora el Día Mundial contra la Hepatitis gTt / 29 July 2013 La OMS pide implicación a los gobiernos contra la hepatitis, que causa 1,4 millones de muertes cada año Hepatitis 2000 / 25 July 2013 More Do you work for a hepatitis organisation?Add your organisation to the listings >